EC
EVH icon

Elequin Capital’s Evolent Health EVH Stock Holding History

Elequin Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5 Sell
1
-13
-93% -$50 ﹤0.01% 692
2026
Q1 		$32 Sell
14
-46
-77% -$146 ﹤0.01% 619
2025
Q4 		$240 Buy
+60
New +$334 ﹤0.01% 395
2025
Q1 		– Sell
-152
Closed -$1.71K – 419
2024
Q4 		$1.71K Sell
152
-236
-61% -$4.15K ﹤0.01% 450
2024
Q3 		$11K Buy
+388
New +$10K ﹤0.01% 229

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Elequin Capital's EVH Position: Q2 2026 in Review

Elequin Capital reduced its Evolent Health (EVH) stake by 93% in Q2 2026, selling an estimated $50 and leaving 1 share worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #692.

Elequin Capital first reported a position in EVH in Q3 2024 and has held it in 5 quarters since. The position peaked at $11K in Q3 2024. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Elequin Capital held 1 share of Evolent Health worth $5 as of Q2 2026.
  • Elequin Capital sold 13 Evolent Health shares in Q2 2026, an estimated $50.
  • Evolent Health made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #692 holding.
  • Elequin Capital first reported a position in Evolent Health in Q3 2024 and has held it in 5 quarters since.
  • Elequin Capital's Evolent Health position peaked at $11K in Q3 2024.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.